Open AccessCertolizumab pegol for the treatment of rheumatoid arthritis
Author(s) -
Nevsun İnanç
Publication year - 2015
Publication title -
raed dergisi
Language(s) - Turkish
Resource type - Journals
eISSN - 2147-2548
pISSN - 1301-4021
DOI - 10.2399/raed.15.s1s1
Subject(s) - certolizumab pegol , rheumatoid arthritis , medicine , adalimumab
‹letiflim / Correspondence: Prof. Dr. Nevsun ‹nanc. Marmara Universitesi T›p Fakultesi, Romatoloji Bilim Dal›, ‹stanbul. e-posta: inanc.nevsun@gmail.com C›kar cak›flmas› / Conflicts of interest: C›kar cak›flmas› bulunmad›¤› belirtilmifltir. / No conflicts declared. www.raeddergisi.org doi:10.2399/raed.15.S1S1 Karekod / QR code: Sertolizumab pegolun (CZP) romatoid artritteki (RA) kullan›m› hafif, orta veya fliddetli aktif RA’s› olan eriflkinlerde monoterapi veya di¤er DMARD’lar ile kombine olarak cok say›da randomize kontrollu klinik cal›flmada araflt›r›lm›flt›r. CZP Monoterapi ve MTX D›fl› DMARD Kombinasyonu ‹lk yap›lan klinik cal›flmalardan biri olan FAST4WARD isimli 24 haftal›k randomize, cift kor, cok merkezli, plasebo kontrollu cal›flmada 4 haftada bir 400 Romatoid artritte sertolizumab pegol (CZP) kullan›m›
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom